論文 - 森瀬 昌宏
-
Non-invasive early prediction of immune checkpoint inhibitor efficacy in non-small-cell lung cancer patients using on-treatment serum CRP and NLR 査読有り 国際誌
Matsuzawa Reiko, Morise Masahiro, Kinoshita Fumie, Tanaka Ichidai, Koyama Junji, Kimura Tomoki, Kondoh Yasuhiro, Tanaka Taro, Shima Koichiro, Hase Tetsunari, Wakahara Keiko, Ishii Makoto, Hashimoto Naozumi
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 2022年8月
-
Weekly nanoparticle albumin-bound paclitaxel and paclitaxel for relapsed small cell lung cancer A retrospective observational study 査読有り 国際誌
Oi Hajime, Matsuda Toshiaki, Kimura Tomoki, Morise Masahiro, Yamano Yasuhiko, Yokoyama Toshiki, Kataoka Kensuke, Kondoh Yasuhiro
MEDICINE 101 巻 ( 6 ) 頁： e28863 2022年2月
-
Trastuzumab emtansine for patients with non-small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutations 査読有り 国際誌
Iwama Eiji, Zenke Yoshitaka, Sugawara Shunichi, Daga Haruko, Morise Masahiro, Yanagitani Noriko, Sakamoto Tomohiro, Murakami Haruyasu, Kishimoto Junji, Matsumoto Shingo, Nakanishi Yoichi, Goto Koichi, Okamoto Isamu
EUROPEAN JOURNAL OF CANCER 162 巻 頁： 99 - 106 2022年2月
-
Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE 査読有り 国際誌
Hata Akito, Okamoto Isamu, Inui Naoki, Okada Morihito, Morise Masahiro, Akiyoshi Kohei, Takeda Masayuki, Watanabe Yasutaka, Sugawara Shunichi, Shinagawa Naofumi, Kubota Kaoru, Saeki Toshiaki, Tamura Tomohide
JOURNAL OF CLINICAL ONCOLOGY 40 巻 ( 2 ) 頁： 180 - + 2022年1月
-
Is area under the curve the best parameter for carboplatin induced emetic risk stratification? 査読有り 国際誌
Ozone Sachiko, Ichikawa Kazuya, Morise Masahiro, Matsui Akira, Kinoshita Fumie, Matsuzawa Reiko, Koyama Junji, Tanaka Ichidai, Hashimoto Naozumi
NAGOYA JOURNAL OF MEDICAL SCIENCE 83 巻 ( 4 ) 頁： 773 - 785 2021年11月
-
The current issues and future perspective of artificial intelligence for developing new treatment strategy in non-small cell lung cancer: harmonization of molecular cancer biology and artificial intelligence 査読有り 国際誌
Tanaka Ichidai, Furukawa Taiki, Morise Masahiro
CANCER CELL INTERNATIONAL 21 巻 ( 1 ) 頁： 454 2021年8月
-
Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma. 査読有り 国際誌
Nakagawa K, Kijima T, Okada M, Morise M, Kato M, Hirano K, Fujimoto N, Takenoyama M, Yokouchi H, Ohe Y, Hida T, Aoe K, Kishimoto T, Hirokawa M, Matsuki H, Kaneko Y, Yamada T, Morimoto C, Takeda M
JTO clinical and research reports 2 巻 ( 6 ) 頁： 100178 2021年6月
-
Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With <i>EGFR</i> Mutations. 査読有り 国際誌
Ninomiya K, Teraoka S, Zenke Y, Kenmotsu H, Nakamura Y, Okuma Y, Tamiya A, Nosaki K, Morise M, Aokage K, Oya Y, Kozuki T, Sakamoto T, Tanaka K, Tanaka H, Tanizaki J, Miura S, Mizutani H, Miyauchi E, Yamaguchi O, Ebi N, Goto Y, Sasaki T, Daga H, Morita S, Yamanaka T, Amano S, Hasegawa K, Imamura CK, Suzuki K, Nakajima K, Nishimoto H, Oizumi S, Hida T, Hotta K, Takiguchi Y
JTO clinical and research reports 2 巻 ( 1 ) 頁： 100107 2021年1月
-
新型コロナウイルス感染症に対するSARS-CoV-2抗体検査試薬の検討―抗原種の違いによる特性と抗体アイソタイプの関連― 査読有り 国際誌
金 貞姫, 菊地 良介, 鈴木 敦夫, 度會 理佳, 横山 覚, 森瀬 昌宏, 八木 哲也, 松下 正
医学検査 69 巻 ( 4 ) 頁： 554 - 561 2020年10月
-
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC 査読有り 国際共著 国際誌
Herbst Roy S., Giaccone Giuseppe, de Marinis Filippo, Reinmuth Niels, Vergnenegre Alain, Barrios Carlos H., Morise Masahiro, Felip Enriqueta, Andric Zoran, Geater Sarayut, Ozguroglu Mustafa, Zou Wei, Sandler Alan, Enquist Ida, Komatsubara Kimberly, Deng Yu, Kuriki Hiroshi, Wen Xiaohui, McCleland Mark, Mocci Simonetta, Jassem Jacek, Spigel David R.
NEW ENGLAND JOURNAL OF MEDICINE 383 巻 ( 14 ) 頁： 1328 - 1339 2020年10月
-
Multicenter, placebo-controlled, double-blind, randomized study of fosnetupitant in combination with palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy 査読有り 国際誌
Sugawara Shunichi, Inui Naoki, Kanehara Masashi, Morise Masahiro, Yoshimori Kozo, Kumagai Toru, Fukui Tomoya, Minato Koichi, Iwashima Akira, Takeda Yuichiro, Kubota Kaoru, Saeki Toshiaki, Tamura Tomohide
CANCER 125 巻 ( 22 ) 頁： 4076 - 4083 2019年11月
-
The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV 査読有り 国際誌
Akamatsu Hiroaki, Ninomiya Kiichiro, Kenmotsu Hirotsugu, Morise Masahiro, Daga Haruko, Goto Yasushi, Kozuki Toshiyuki, Miura Satoru, Sasaki Takaaki, Tamiya Akihiro, Teraoka Shunsuke, Tsubata Yukari, Yoshioka Hiroshige, Hattori Yoshihiro, Imamura Chiyo K., Katsuya Yuki, Matsui Reiko, Minegishi Yuji, Mizugaki Hidenori, Nosaki Kaname, Okuma Yusuke, Sakamoto Setsuko, Sone Takashi, Tanaka Kentaro, Umemura Shigeki, Yamanaka Takeharu, Amano Shinsuke, Hasegawa Kazuo, Morita Satoshi, Nakajima Kazuko, Maemondo Makoto, Seto Takashi, Yamamoto Nobuyuki
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 24 巻 ( 7 ) 頁： 731 - 770 2019年7月
-
12）高齢者肺癌の臨床 国際誌
長谷川 好規, 森瀬 昌宏
日本内科学会雑誌 106 巻 ( 9 ) 頁： 1986 - 1990 2017年9月
-
Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis 査読有り 国際誌
Gen Soei, Tanaka Ichidai, Morise Masahiro, Koyama Junji, Kodama Yuta, Matsui Akira, Miyazawa Ayako, Hase Tetsunari, Hibino Yoshitaka, Yokoyama Toshihiko, Kimura Tomoki, Yoshida Norio, Sato Mitsuo, Hashimoto Naozumi
BMC CANCER 22 巻 ( 1 ) 頁： 654 2022年6月
-
Amelanotic Malignant Melanoma with a BRAF V600E Mutation Mimicking Primary Lung Cancer 査読有り 国際誌
Matsuzawa Reiko, Morise Masahiro, Tanaka Ichidai, Hayai Shunsaku, Tamiya Yutaro, Koyama Junji, Hase Tetsunari, Wakahara Keiko, Kim Deoksu, Shimoyama Yoshie, Hashimoto Naozumi
INTERNAL MEDICINE 61 巻 ( 5 ) 頁： 703 - 708 2022年5月
-
Resistance to mutant KRASV12-induced senescence in an hTERT/Cdk4-immortalized normal human bronchial epithelial cell line 査読有り 国際共著
Muraki N, Yamada M, Doki H, Nakai R, Komeda K, Goto D, Kawabe N, Matsuoka K, Matsushima M, Kawabe T, Tanaka I, Morise M, Shay JW, Minna JD, Sato M.
Exp Cell Res 414 巻 ( 1 ) 頁： 113053 2022年5月
-
Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE) 査読有り 国際誌
Hata Akito, Shiraishi Yoshimasa, Inui Naoki, Okada Morihito, Morise Masahiro, Akiyoshi Kohei, Takeda Masayuki, Watanabe Yasutaka, Sugawara Shunichi, Shinagawa Naofumi, Kubota Kaoru, Saeki Toshiaki, Tamura Tomohide
ONCOLOGY AND THERAPY 2022年3月
-
INSIGHT 2: a Phase II study of tepotinib plus osimertinib in MET-amplified NSCLC and first-line osimertinib resistance 査読有り 国際共著 国際誌
Smit Egbert F., Dooms Christophe, Raskin Jo, Nadal Ernest, Tho Lye M., Le Xiuning, Mazieres Julien, Hin How S., Morise Masahire, Zhu Viola W., Tan Daniel, Holmberg Kristina H., Ellers-Lenz Barbara, Adrian Svenja, Brutlach Sabine, Schumacher Karl M., Karachaliou Niki, Wu Yi-Long
FUTURE ONCOLOGY 18 巻 ( 9 ) 頁： 1039 - 1054 2022年3月
-
Current Immunotherapeutic Strategies Targeting the PD-1/PD-L1 Axis in Non-Small Cell Lung Cancer with Oncogenic Driver Mutations 査読有り 国際誌
Tanaka Ichidai, Morise Masahiro
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 23 巻 ( 1 ) 2022年1月
-
A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer 査読有り 国際誌
Yasuda Hiroyuki, Ichihara Eiki, Sakakibara-Konishi Jun, Zenke Yoshitaka, Takeuchi Shinji, Morise Masahiro, Hotta Katsuyuki, Sato Mineyoshi, Matsumoto Shingo, Tanimoto Azusa, Matsuzawa Reiko, Kiura Katuyuki, Takashima Yuta, Yano Seiji, Koyama Junji, Fukushima Takahiro, Hamamoto Junko, Terai Hideki, Ikemura Shinnosuke, Takemura Ryo, Goto Koichi, Soejima Kenzo
LUNG CANCER 162 巻 頁： 140 - 146 2021年12月
-
Oxytocin receptor is a promising therapeutic target of malignant mesothelioma 査読有り 国際誌
Kodama Yuta, Tanaka Ichidai, Sato Tatsuhiro, Hori Kazumi, Gen Soei, Morise Masahiro, Matsubara Daisuke, Sato Mitsuo, Sekido Yoshitaka, Hashimoto Naozumi
CANCER SCIENCE 112 巻 ( 9 ) 頁： 3520 - 3532 2021年9月
-
A multicenter cohort study of osimertinib compared with afatinib as first-line treatment for EGFR-mutated non-small-cell lung cancer from practical dataset: CJLSG1903 査読有り 国際誌
Ito K., Morise M., Wakuda K., Hataji O., Shimokawaji T., Takahashi K., Furuya N., Takeyama Y., Goto Y., Abe T., Kato T., Ozone S., Ikeda S., Kogure Y., Yokoyama T., Kimura M., Yoshioka H., Murotani K., Kondo M., Saka H.
ESMO OPEN 6 巻 ( 3 ) 2021年6月
-
Shiraishi, Y; Hata, A; Inui, N; Okada, M; Morise, M; Akiyoshi, K; Takeda, M; Watanabe, Y; Sugawara, S; Shinagawa, N; Kubota, K; Saeki, T; Tamura, T
JOURNAL OF CLINICAL ONCOLOGY 39 巻 ( 15 ) 2021年5月
-
IMpower110: Updated OS Analysis of Atezolizumab vs Platinum-Based Chemotherapy as First-Line Treatment in PD-L1-Selected NSCLC 査読有り 国際共著 国際誌
Herbst R., De Marinis F., Giaccone G., Vergnenegre A., Barrios C., Morise M., Felip E., Oprean C., Kim Y., Andric Z., Mocci S., Enquist I., Komatsubara K., Mccleland M., Deng Y., Kuriki H., Villalobos M., Phan S., Spigel D., Jassem J.
JOURNAL OF THORACIC ONCOLOGY 16 巻 ( 3 ) 頁： S224 - S225 2021年3月
-
Lorlatinib in previously treated anaplastic lymphoma kinase-rearranged non-small cell lung cancer: Japanese subgroup analysis of a global study 査読有り 国際共著 国際誌
Seto Takashi, Hayashi Hidetoshi, Satouchi Miyako, Goto Yasushi, Niho Seiji, Nogami Naoyuki, Hida Toyoaki, Takahashi Toshiaki, Sakakibara-Konishi Jun, Morise Masahiro, Nagasawa Takashi, Suzuki Mie, Ohkura Masayuki, Fukuhara Kei, Thurm Holger, Peltz Gerson, Nishio Makoto
CANCER SCIENCE 111 巻 ( 10 ) 頁： 3726 - 3738 2020年10月
-
Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study 査読有り 国際誌
Nakano Takashi, Kuribayashi Kozo, Kondo Masashi, Morise Masahiro, Tada Yuji, Hirano Katsuya, Hayashi Morihiko, Tanaka Misa, Hirabayashi Masataka
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 2020年9月
-
Clinical burden of immune checkpoint inhibitor-induced pneumonitis 査読有り 国際誌
Sakamoto Koji, Fukihara Jun, Morise Masahiro, Hashimoto Naozumi
RESPIRATORY INVESTIGATION 58 巻 ( 5 ) 頁： 305 - 319 2020年9月
-
Primary Prophylaxis Indication for Docetaxel Induced Febrile Neutropenia in Elderly Patients with Non-Small Cell Lung Cancer 査読有り 国際誌
Matsui Akira, Morise Masahiro, Tanaka Ichidai, Ozone Sachiko, Matsuzawa Reiko, Koyama Junji, Hase Tetsunari, Hashimoto Naozumi, Sato Mitsuo, Hasegawa Yoshinori
CANCER INVESTIGATION 38 巻 ( 7 ) 頁： 424 - 430 2020年8月
-
Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer Patients With EGFR Mutation 査読有り 国際誌
Tanaka Ichidai, Morise Masahiro, Miyazawa Ayako, Kodama Yuta, Tamiya Yutaro, Gen Soei, Matsui Akira, Hase Tetsunari, Hashimoto Naozumi, Sato Mitsuo, Hasegawa Yoshinori
CLINICAL LUNG CANCER 21 巻 ( 3 ) 頁： 273 - + 2020年5月
-
Reply to "Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With NoneSmall-Cell Lung Cancer Who Received Programmed Death-1 Inhibitors" 査読有り 国際誌
Fukihara Jun, Sakamoto Koji, Koyama Junji, Ito Takayasu, Iwano Shingo, Morise Masahiro, Ogawa Masahiro, Kondoh Yasuhiro, Kimura Tomoki, Hashimoto Naozumi, Hasegawa Yoshinori
CLINICAL LUNG CANCER 21 巻 ( 3 ) 頁： E205 - E205 2020年5月
-
UHRF1, a Regulator of Methylation, as a Diagnostic and Prognostic Marker for Lung Cancer 査読有り 国際誌
Goto Daiki, Komeda Kazuki, Uwatoko Natsuki, Nakashima Moeka, Koike Mayu, Kawai Kaho, Kodama Yuta, Miyazawa Ayako, Tanaka Ichidai, Hase Tetsunari, Morise Masahiro, Hasegawa Yoshinori, Kawabe Tsutomu, Sato Mitsuo
CANCER INVESTIGATION 38 巻 ( 4 ) 頁： 240 - 249 2020年4月
-
Phase II, open-label, multicenter trial of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study 査読有り 国際誌
Shimokawa Mototsugu, Nosaki Kaname, Seto Takashi, Ohashi Kadoaki, Morise Masahiro, Horinouchi Hidehito, Sakakibara Jun, Murakami Haruyasu, Yano Seiji, Satouchi Miyako, Matsumoto Shingo, Goto Koichi, Yoh Kiyotaka
TRIALS 21 巻 ( 1 ) 2020年3月
-
Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study 査読有り 国際誌
Okada Norio, Iwama Shintaro, Okuji Takayuki, Kobayashi Tomoko, Yasuda Yoshinori, Wada Eri, Onoue Takeshi, Goto Motomitsu, Sugiyama Mariko, Tsunekawa Taku, Takagi Hiroshi, Hagiwara Daisuke, Ito Yoshihiro, Suga Hidetaka, Banno Ryoichi, Hase Tetsunari, Morise Masahiro, Kanda Mitsuro, Yokota Kenji, Hashimoto Naozumi, Ando Masahiko, Fujimoto Yasushi, Nagino Masato, Kodera Yasuhiro, Fujishiro Mitsuhiro, Hibi Hideharu, Sone Michihiko, Kiyoi Hitoshi, Gotoh Momokazu, Ando Yuichi, Akiyama Masashi, Hasegawa Yoshinori, Arima Hiroshi
BRITISH JOURNAL OF CANCER 122 巻 ( 6 ) 頁： 771 - 777 2020年3月
-
Risk factors for pulmonary infection after diagnostic bronchoscopy in patients with lung cancer 査読有り 国際誌
Shimizu Takahiro, Okachi Shotaro, Imai Naoyuki, Hase Tetsunari, Morise Masahiro, Hashimoto Naozumi, Sato Mitsuo, Hasegawa Yoshinori
NAGOYA JOURNAL OF MEDICAL SCIENCE 82 巻 ( 1 ) 頁： 69 - 77 2020年2月
-
Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer 査読有り 国際誌
Nakagawa Kazuhiko, Hida Toyoaki, Nokihara Hiroshi, Morise Masahiro, Azuma Koichi, Kim Young Hak, Seto Takashi, Takiguchi Yuichi, Nishio Makoto, Yoshioka Hiroshige, Kumagai Toru, Hotta Katsuyuki, Watanabe Satoshi, Goto Koichi, Satouchi Miyako, Kozuki Toshiyuki, Koyama Ryo, Mitsudomi Tetsuya, Yamamoto Nobuyuki, Asakawa Takashi, Hayashi Morihiko, Hasegawa Wakako, Tamura Tomohide
LUNG CANCER 139 巻 頁： 195 - 199 2020年1月
-
Pituitary dysfunction induced by immune checkpoint inhibitors is associated with better overall survival in both malignant melanoma and non-small cell lung carcinoma: a prospective study 査読有り 国際誌
Kobayashi Tomoko, Iwama Shintaro, Yasuda Yoshinori, Okada Norio, Okuji Takayuki, Ito Masaaki, Onoue Takeshi, Goto Motomitsu, Sugiyama Mariko, Tsunekawa Taku, Takagi Hiroshi, Hagiwara Daisuke, Ito Yoshihiro, Suga Hidetaka, Banno Ryoichi, Yokota Kenji, Hase Tetsunari, Morise Masahiro, Hashimoto Naozumi, Ando Masahiko, Fujimoto Yasushi, Hibi Hideharu, Sone Michihiko, Ando Yuichi, Akiyama Masashi, Hasegawa Yoshinori, Arima Hiroshi
JOURNAL FOR IMMUNOTHERAPY OF CANCER 8 巻 ( 2 ) 2020年
-
Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non-Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors 査読有り 国際誌
Fukihara Jun, Sakamoto Koji, Koyama Junji, Ito Takayasu, Iwano Shingo, Morise Masahiro, Ogawa Masahiro, Kondoh Yasuhiro, Kimura Tomoki, Hashimoto Naozumi, Hasegawa Yoshinori
CLINICAL LUNG CANCER 20 巻 ( 6 ) 頁： 442 - + 2019年11月
-
Potential for afatinib as an optimal treatment for advanced non-small cell lung carcinoma in patients with uncommon EGFR mutations 査読有り 国際誌
Tanaka Ichidai, Morise Masahiro, Kodama Yuta, Matsui Akira, Ozawa Naoya, Ozone Sachiko, Goto Daiki, Miyazawa Ayako, Hase Tetsunari, Hashimoto Naozumi, Sato Mitsuo, Hasegawa Yoshinori
LUNG CANCER 127 巻 頁： 169 - 171 2019年1月
-
eIF2 beta, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancer 査読有り 国際共著 国際誌
Tanaka Ichidai, Sato Mitsuo, Kato Toshio, Goto Daiki, Kakumu Tomohiko, Miyazawa Ayako, Yogo Naoyuki, Hase Tetsunari, Morise Masahiro, Sekido Yoshitaka, Girard Luc, Minna John D., Byers Lauren A., Heymach John V., Coombes Kevin R., Kondo Masashi, Hasegawa Yoshinori
CANCER SCIENCE 109 巻 ( 6 ) 頁： 1843 - 1852 2018年6月
-
Safety and efficacy of diagnostic flexible bronchoscopy in very old patients with lung cancer
Okachi Shotaro, Imaizumi Kazuyoshi, Imai Naoyuki, Shimizu Takahiro, Hase Tetsunari, Morise Masahiro, Hashimoto Naozumi, Sato Mitsuo, Hasegawa Yoshinori
EUROPEAN GERIATRIC MEDICINE 9 巻 ( 2 ) 頁： 255-262 2018年4月
-
Prospective registry database of patients with malignant mesothelioma: directions for a future Japanese registry-based lung cancer study 査読有り 国際誌
Shintani Yasushi, Hasegawa Seiki, Takuwa Teruhisa, Aoe Keisuke, Kato Katsuya, Fujimoto Nobukazu, Hida Yasuhiro, Morise Masahiro, Moriya Yasumitsu, Morohoshi Takao, Okumura Meinoshin, Yoshino Ichiro
JOURNAL OF THORACIC DISEASE 10 巻 ( 3 ) 頁： 1968 - 1971 2018年3月
-
Patients With Antithyroid Antibodies Are Prone To Develop Destructive Thyroiditis by Nivolumab: A Prospective Study 査読有り 国際誌
Kobayashi Tomoko, Iwama Shintaro, Yasuda Yoshinori, Okada Norio, Tsunekawa Taku, Onoue Takeshi, Takagi Hiroshi, Hagiwara Daisuke, Ito Yoshihiro, Morishita Yoshiaki, Goto Motomitsu, Suga Hidetaka, Banno Ryoichi, Yokota Kenji, Hase Tetsunari, Morise Masahiro, Hashimoto Naozumi, Ando Masahiko, Kiyoi Hitoshi, Gotoh Momokazu, Ando Yuichi, Akiyama Masashi, Hasegawa Yoshinori, Arima Hiroshi
JOURNAL OF THE ENDOCRINE SOCIETY 2 巻 ( 3 ) 頁： 241 - 251 2018年3月
-
Tanaka Ichidai, Kawada Kenji, Morise Masahiro, Hase Tetsunari, Hayashi Hiroaki, Sokai Akihiko, Fukatsu Asuki, Kondo Masashi, Nomura Fumio, Hasegawa Yoshinori
CANCER CHEMOTHERAPY AND PHARMACOLOGY 81 巻 ( 2 ) 頁： 339 - 345 2018年2月
-
Sato Mitsuo, Matsui Akira, Shimoyama Yoshie, Omote Norihito, Morise Masahiro, Hase Tetsunari, Tanaka Ichidai, Suzuki Kojiro, Hasegawa Yoshinori
Internal Medicine 57 巻 ( 23 ) 頁： 3429 - 3432 2018年
-
Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer 査読有り 国際共著 国際誌
Kakumu Tomohiko, Sato Mitsuo, Goto Daiki, Kato Toshio, Yogo Naoyuki, Hase Tetsunari, Morise Masahiro, Fukui Takayuki, Yokoi Kohei, Sekido Yoshitaka, Girard Luc, Minna John D., Byers Lauren A., Heymach John V., Coombes Kevin R., Kondo Masashi, Hasegawa Yoshinori
CANCER SCIENCE 108 巻 ( 4 ) 頁： 732 - 743 2017年4月
-
Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy. 査読有り
Omote N, Hashimoto N, Morise M, Sakamoto K, Miyazaki S, Ando A, Nakahara Y, Hasegawa Y.
Int J Chron Obstruct Pulmon Dis. 11 巻 ( 12 ) 頁： 3541-3547 2017年
-
Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy 査読有り 国際誌
Omote Norihito, Hashimoto Naozumi, Morise Masahiro, Sakamoto Koji, Miyazaki Shinichi, Ando Akira, Nakahara Yoshio, Hasegawa Yoshinori
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 巻 頁： 3541 - 3547 2017年
-
Factors Affecting the Diagnostic Yield of Transbronchial Biopsy Using Endobronchial Ultrasonography with a Guide Sheath in Peripheral Lung Cancer. 査読有り
Okachi S, Imai N, Imaizumi K, Iwano S, Ando M, Hase T, Aso H, Morise M, Wakahara K, Ito S, Hashimoto N, Sato M, Kondo M, Hasegawa Y
Intern Med 55 巻 ( 13 ) 頁： 1705-12 2016年
-
The association of intravascular stromal cells with prognosis in high-grade neuroendocrine carcinoma of the lung 査読有り
Sekihara K, Hishida T, Ikemura S, Saruwatari K, Morise M, Kuwata T, Fujii S, Kojima M, Ochiai A, Funai K, Aokage K, Yoshida J, Tsuboi M, Ishii G
J Cancer Res Clin Oncol 142 巻 ( 5 ) 頁： 905-912 2016年
-
Can we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy? 査読有り
Kato T, Morise M (equal first author), Ando M, Kojima E, Ogasawara T, Suzuki R, Shindoh J, Matsumoto M, Sugino Y, Ogawa M, Nozaki Y, Hase T, Kondo M, Saito H, Hasegawa Y
Can we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy? 142 巻 ( 7 ) 頁： 1629-40 2016年
-
Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lung 査読有り
Udagawa H, Ishii G, Morise M, Umemura S, Matsumoto S, Yoh K, Niho S, Ohmatsu H, Tsuboi M, Goto K, Ochiai A, Ohe Y
J Cancer Res Clin Oncol 141 巻 ( 8 ) 頁： 1417-25. 2015年
-
Presence of podoplanin-positive cancer-associated fibroblasts in surgically resected primary lung adenocarcinoma predicts a shorter progression-free survival period in patients with recurrences who received platinum-based chemotherapy
Koriyama H, Ishii G, Yoh K, Neri S, Morise M, Umemura S, Matsumoto S, Niho S, Ohmatsu H, Tsuboi M, Goto K, Ochiai A
J Cancer Res Clin Oncol 141 巻 ( 7 ) 頁： 1163-70 2015年
-
Drastic morphological and molecular differences between lymph node micrometastatic tumors and macrometastatic tumors of lung adenocarcinoma 査読有り
Aramaki N, Ishii G, Yamada E, Morise M, Aokage K, Kojima M, Hishida T, Yoshida J, Ikeda N, Tsuboi M, Ochiai A
142 巻 ( 1 ) 頁： 37-46 2015年
-
Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung 査読有り
Morise M, Hishida T, Takahashi A, Yoshida J, Ohe Y, Nagai K, Ishii G
Journal of cancer research and clinical oncology 頁： 2015 May 12. [Epub ahead of print] 2015年
-
環境因子と呼吸器悪性腫瘍 招待有り
森瀬昌宏, 長谷川好規
呼吸と循環 62 巻 ( 10 ) 頁： 963-968 2014年
-
最新がん薬物療法学 小細胞肺癌 招待有り
森瀬昌宏, 後藤功一
日本臨床 増刊号 72 巻 ( 2 ) 頁： 346-349 2014年
-
Phase II study of erlotinib for previously treated patients with EGFR wild-type non-small-cell lung cancer, following EGFR mutation status reevaluation with the Scorpion Amplified Refractory Mutation System 査読有り
Morise M, Taniguchi H, Saka H, Shindoh J, Suzuki R, Kojima E, Hase T, Ando M, Kondo M, Saito H, Hasegawa Y
Mol Clin Oncol 2 巻 ( 6 ) 頁： 991-996 2014年
-
Low-dose Irinotecan as a Second-line Chemotherapy for Recurrent Small Cell Lung Cancer 査読有り
Morise M, Niho S, Umemura S, Matsumoto S, Yoh K, Goto K, Ohmatsu H, Ohe Y
Jpn J Clin Oncol 44 巻 ( 9 ) 頁： 846-51 2014年
-
Therapeutic Priority of the PI3K/AKT/mTOR Pathway in Small Cell Lung Cancers as Revealed by a Comprehensive Genomic Analysis 査読有り
9 巻 ( 9 ) 頁： 1324-31 2014年
-
特集 オンコロジーエマージェンシーと支持療法の進歩 抗がん剤による過敏反応，インフュージョンリアクション 招待有り
森瀬昌宏, 後藤功一
呼吸器内科 23 巻 頁： 261-267 2013年
-
講座 肺癌化学療法の最前線 小細胞肺癌に対する化学療法 招待有り
森瀬昌宏, 後藤功一
呼吸 32 巻 ( 7 ) 頁： 631-637 2013年
-
Nongenomic effects of fluticasone propionate and budesonide on human airway anion secretion 査読有り
Mizutani T, Morise M, Ito Y, Hibino Y, Matsuno T, Ito S, Hashimoto N, Sato M, Kondo M, Imaizumi K, Hasegawa Y
Am J Respir Cell Mol Biol 47 巻 ( 5 ) 頁： 645-51 2012年
-
Capsaicinoids regulate airway anion transporters through Rho kinase- and cyclic AMP-dependent mechanisms 査読有り
Hibino Y, Morise M, Ito Y, Mizutani T, Matsuno T, Ito S, Hashimoto N, Sato M, Kondo M, Imaizumi K, Hasegawa Y
Am J Respir Cell Mol Biol 45 巻 ( 4 ) 頁： 684-91 2011年
-
Heterologous regulation of anion transporters by menthol in human airway epithelial cells 査読有り
Morise M, Ito Y, Matsuno T, Hibino Y, Mizutani T, Ito S, Hashimoto N, Kondo M, Imaizumi K, Hasegawa Y
Eur J Pharmacol 10 巻 ( 635 ) 頁： 204-211 2010年
-
Dual pathway activated by tert-butyl hydroperoxide in human airway anion secretion
Matsuno T, Ito Y, Ohashi T, Morise M, Takeda N, Shimokata K, Imaizumi K, Kume H, Hasegawa Y
J Pharmacol Exp Ther 327 巻 ( 2 ) 頁： 453-64 2008年
-
肺病変を伴ったmulticentiric Castleman’s diseaseの一例 査読有り
森瀬昌宏, 下元博史, 本多 豊大, 森 良雄
日本呼吸器学会誌 41 巻 頁： 59-65 2003年
-
胸壁原発悪性線維性組織球腫の1例 査読有り
下元博史, 森瀬昌宏, 佐藤榮作, 山内晶司
日本胸部臨床 62 巻 ( 6 ) 頁： 561 -566 2003年